Memorial Sloan Kettering

April 2018 Newsletter

Issue link: http://read.uberflip.com/i/961959

Contents of this Issue

Navigation

Page 1 of 3

CAR T cell therapy engineers a patient's own cells to recognize a protein present in cancer cells, enabling them to seek out and destroy the cancer. PAGE 2 Reflecting on the Future | Spring 2018 In May, Ernie's friend underwent a bone marrow transplant as a next step. For the next three months, The Red Team at one of MSK's outpatient clinics administered medications, monitored his vitals, and treated fevers and other conditions that sometimes occur in the difficult aftermath of the treatment. Throughout it all, Ernie provided support alongside family and friends. When a scan showed no evidence of cancer, Ernie rejoiced with his friend and the MSK teams he'd come to know so well. Touched by the care he witnessed, Ernie included MSK's bone marrow transplant service, in honor of The Red Team, as a beneficiary in his will. He feels good about the gesture and knows it will enable more patients to benefit from MSK's extraordinary care and leading-edge treatments, including CAR T cell therapy, in the future. Ernie's generosity also goes a long way in fulfilling his pledge to do more to help others. For not just one man, but two, it has been the journey of a lifetime. The Extra Mile Continued from Page 1 When you include a gift to MSK in your estate plan to recognize the care you or someone close to you received, you provide the resources we need to make more medical breakthroughs. If you have already made a gift to MSK, please contact us at 800-688-1827 or plannedgiving@mskcc.org so that we can better prepare for the future and thank you for your gift. Honor Someone Special Encourage More Research MSK Leads Discovery Your generosity helps MSK take the lead in developing promising new therapies such as chimeric antigen receptor (CAR) T cell therapy. This breakthrough treatment engineers a patient's own cells to recognize a protein present in cancer cells, enabling them to seek out and destroy the cancer. Such CAR T cells have shown great promise in beating back some blood cancers that have stopped responding to other therapies. CAR T cells are also being explored as a treatment for several other types of cancer, including lymphoma, lung cancer, breast cancer, mesothelioma, ovarian cancer, and multiple myeloma. MSK hematologic oncologist Dr. Craig Sauter and other experts use this revolutionary immune therapy to help treat multiple forms of advanced cancer.

Articles in this issue

Links on this page

view archives of Memorial Sloan Kettering - April 2018 Newsletter